United States · FDA National Drug Code directory
Talzenna
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63539-031_b653221e-971f-4452-92d4-797924f1ff59
- Product NDC
- 63539-031
- Form
- CAPSULE, LIQUID FILLED
- Composition / generic term
- talazoparib
- Labeler
- U.S. Pharmaceuticals
- Marketing category
- NDA
- Marketing start / end (source format)
- 20240709
- Source listing expiry
- 20271231
Source-listed ingredients
- TALAZOPARIB TOSYLATE — 1 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE, LIQUID FILLED in 1 BOTTLE (63539-031-30) · 63539-031-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →